Oramed Pharmaceuticals Inc.
CIK: 0001176309
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LFWD
Lifeward Ltd.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About ORAMED PHARMACEUTICALS INC.
ORAMED PHARMACEUTICALS INC. (SEC CIK 0001176309) files insider reports with the SEC as 10% Owner of Lifeward Ltd. (LFWD).
Signal8 holds 1 ownership filing by ORAMED PHARMACEUTICALS INC., a Form 3, filed on May 14, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on ORAMED PHARMACEUTICALS INC.'s filings is in NEW YORK, NY.
Other insiders filing for Lifeward Ltd. (LFWD)
- Zamir Haggai, Director
- Hexter Joshua, Officer
- Greenwald Yonason, Director
- Gabay Avraham, Director
- Rose Keith Dale, Chief Medical Officer
- Sigsbee William Mark, Director